Premium
Effect of time from diagnosis to start of radiotherapy on children with diffuse intrinsic pontine glioma
Author(s) -
Pai Panandiker Atmaram S.,
Wong J. Karen,
Nedelka Michele A.,
Wu Shengjie,
Gajjar Amar,
Broniscer Alberto
Publication year - 2014
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.24971
Subject(s) - medicine , glioma , radiation therapy , cohort , hazard ratio , proportional hazards model , retrospective cohort study , pediatrics , oncology , confidence interval , cancer research
Background Children with diffuse intrinsic pontine glioma (DIPG) continue to have poor outcomes, and radiotherapy (RT) is the only temporarily effective treatment. In this retrospective analysis, we studied the effect of time from diagnosis to start of RT on event‐free survival (EFS) and overall survival (OS) in children with DIPG. Methods Records of children ( n = 95) with DIPG treated with RT at a single institution between April 1999 and September 2009 were analyzed. RT was delivered at doses of 54.0–55.8 Gy at 1.8 Gy per fraction, and children were followed prospectively. The effect of gender, race, interruption during treatment course, age at diagnosis, duration of symptoms prior to diagnosis, use of protocol‐based chemotherapy, and time from diagnosis to initiation of RT on EFS and OS was assessed by the Cox proportional hazards model. Results Time as a continuous variable from diagnosis to start of RT did not affect outcome. Time dichotomized to ≤14 days significantly affected OS (hazard ratio [HR] = 1.70, P = 0.014) and race other than white or black affected EFS (HR = 2.32, P = 0.017). The 95 patients had a 6‐month EFS and OS of 60 ± 5% and 94.7 ± 2.3%, respectively, and a 12‐month EFS and OS of 11.6 ± 3.1% and 49.5 ± 5%, respectively. Conclusions Time as a continuous variable did not affect OS or EFS in our cohort; however, children treated within 2 weeks of diagnosis had poor outcomes. Although rapid initiation of RT is desirable, our findings do not support intensive efforts aimed at shortening delays from diagnosis to start of RT. Pediatr Blood Cancer 2014;61:1180–1183. © 2014 Wiley Periodicals, Inc.